Press Releases

There are already almost 300 gene and cell therapies in the research and development phase to treat a hundred diseases

R&D efforts in this area have already achieved several effective treatments against different pathologies
Topics:

Europe approved 42 completely new medicines in 2018, 20% more than in the previous year

Cancer, infectious diseases, haematology and neurology made up the majority of the new additions, which also included three gene and cell therapies.

One in four positive rulings of the EMA were aimed at treatments for rare diseases
Topics:

The pharmaceutical industry advocates for collaboration with other healthcare stakeholders to achieve new advances in health

The international federation of the research-based pharmaceutical industry, IFPMA, has renewed its commitment to global health progress in celebration of its 50th anniversary

The pharmaceutical industry can claim several examples of success in recent decades such as vaccines, the fight against HIV and cancer and also the cure for Hepatitis C

In Spain, almost half of the €1,100 million that the pharmaceutical industry invests in R&D is dedicated to collaboration projects with centres and external parties

The Government and Farmaindustria renew the Agreement for Sustainability, Access and Innovation

The Agreement, which will remain in effect throughout 2018, aims to facilitate patient access to therapeutic innovations under equitable conditions and ensure the sustainability of the National Health System
Topics:

Parliamentarians, health care professionals and associations defend the need for patients to actively participate in the public sphere in Spain

FARMAINDUSTRIA remarks that patients are the raison d'etre for those who are part of the health care system

The European biomedical industry urges the United Kingdom and the EU to protect patients’ access to medicines before Brexit

The associations that represent the European and British biomedical industry insist on the importance of ensuring cooperation between the United Kingdom and the European Union in terms of pharmaceutical regulation
Topics:

The General Council of Spanish Advocacy and Transparency International reward the pharmaceutical industry’s commitment to transparency

They recognise that the Code of Good Practice "guarantees that relationships with professionals and health organizations are developed under strict ethical principles".

R&D and training continue to be the basis for collaboration between the pharmaceutical industry and healthcare professionals

For a second year running, the companies adhering to FARMAINDUSTRIA's Transparency Code publish the collaborations with sector agents
Topics:

Transparency, sustainability and innovation, pillars of the social commitment of the pharmaceutical industry

FARMAINDUSTRIA approves its annual report of activities in the Association’s Ordinary General Assembly
Topics:

© 2020 FarmaIndustria All rights reserved